Cell proliferation, as determined by immunocytochemistry, using proliferation antigens Ki-67 and Proliferating Cell Nuclear Antigen (PCNA), is the principal determinant of tumor progression and prognosis. The gene discussed is PCNA; the disease is neoplasm.